Page last updated: 2024-11-06

hydroxyproline and Cardiomyopathy, Hypertrophic

hydroxyproline has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitamura, M1
Shimizu, M1
Kita, Y1
Yoshio, H1
Ino, H1
Misawa, K1
Matsuyama, T1
Mabuchi, H1

Trials

1 trial available for hydroxyproline and Cardiomyopathy, Hypertrophic

ArticleYear
Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer.
    Japanese circulation journal, 1997, Volume: 61, Issue:9

    Topics: Adult; Animals; Cardiomyopathy, Hypertrophic; Cricetinae; Endomyocardial Fibrosis; Evaluation Studie

1997